UNSPSC 85445100: Diagnoses of antiepileptics and antiparkinsonism drugs

In this classification, this covers the group of activities that yields a diagnosis of antiepileptics and antiparkinsonism drugs. Antiepileptics and antiparkinsonism drugs is listed In The World Health Organization's International Statistical Classification of Diseases and Related Health Problems (ICD-10) as a four-character category under code Y46.

ICD-10 also has The following Antiepileptics and antiparkinsonism drugs children in its four-character category: Y46.0 (Succinimides); Y46.1 (Oxazolidinediones); Y46.2 (Hydantoin derivatives); Y46.3 (Deoxybarbiturates); Y46.4 (Iminostilbenes); Y46.5 (Valproic acid); Y46.6 (Other and unspecified antiepileptics); Y46.7 (Antiparkinsonism drugs); Y46.8 (Antispasticity drugs)

UNSPSC 85445100 Diagnoses of antiepileptics and antiparkinsonism drugs is a Class code that shows a significant mismatch between its nominal scope and actual recent state and local procurement activity. The code's abstract framing suggests pharmaceutical diagnostics or therapeutic drug monitoring services, but the three most recent opportunities posted under this code involve diagnostic imaging system procurement (San Mateo Medical Center's PACS implementation), special education contracted services (Birdville Independent School District), and temporary health professional staffing (Santa Clara County Health System). None of these solicitations address antiepileptic or antiparkinsonism drug diagnostics or monitoring. The code appears to reflect a tagging or taxonomy-application error in the source systems rather than legitimate procurement activity aligned with the code's intended scope.

San Mateo County Medical Center (California), Birdville Independent School District (Texas), and Santa Clara County Health System (California) are the issuing bodies posting under this code, spanning county health systems and school districts. Geographic activity concentrates in California and Texas. The source contains no relevant recent opportunities for businesses pursuing work in antiepileptic or antiparkinsonism drug diagnostics or monitoring under this code. Practitioners should verify coding accuracy in jurisdiction procurement systems before investing significant business development effort under this UNSPSC classification.